2025 Annual Meeting | C48 - Child Neurology: Neuro-oncology
Program Materials Program Evaluations
07:00 AM - 07:40 AM PDT | Speaker |
Pediatric CNS Tumors: Review and Treatment Updates
Sonia Partap, MD, FAAN |
07:40 AM - 08:20 AM PDT | Speaker |
Targeted Therapies for Low-Grade Glioma and Neurocutaneous Syndromes
Cynthia Campen, MD |
08:20 AM - 09:00 AM PDT | Speaker |
Beyond the Diagnosis: Long-Term Neurologic Impact of Brain Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN |
Nicole Ullrich, MD, PhD, MMSci, FAAN | Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |
Sonia Partap, MD, FAAN | The institution of Dr. Partap has received research support from NIH. |
Cynthia Campen, MD | Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Campen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms. The institution of Dr. Campen has received research support from Greathouse Family Foundation. |